Azathioprine in early Crohn's disease: time to revisit patient selection and end points for clinical trials and/or azathioprine efficacy?
1st Department of Medicine, Semmelweis University, Budapest, Hungary.
Peter L
PL
Lakatos
IBD Unit, Inserm U954, Nancy University Hospital, France.
Laurent
L
Peyrin-Biroulet
D001379:Azathioprine / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male
D007166:Immunosuppressive Agents; D001379:Azathioprine